Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $3.82 billion as of May 15, 2026. Its market cap has increased by 29.46% in one year.

• Market Cap: 3.82B
• Enterprise Value: 3.06B
• 1-Year Change: 29.46%
• Ranking: #1561
• Category: Mid-Cap
• Stock Price: $31.18

Market Cap Chart

Since November 8, 2006, Catalyst Pharmaceuticals's market cap has increased from $76.40M to $3.82B, an increase of 4,894.55%. That is a compound annual growth rate of 22.17%.

Market Cap History

Date	Market Cap	% Change
May 15, 2026	3.82B	33.01%
Dec 31, 2025	2.87B	15.25%
Dec 31, 2024	2.49B	38.90%
Dec 29, 2023	1.79B	-7.42%
Dec 30, 2022	1.94B	177.28%
Dec 31, 2021	698.10M	101.65%
Dec 31, 2020	346.20M	-10.40%
Dec 31, 2019	386.40M	95.84%
Dec 31, 2018	197.30M	-40.80%
Dec 29, 2017	333.30M	283.10%
Dec 30, 2016	87.00M	-57.12%
Dec 31, 2015	202.90M	-1.17%
Dec 31, 2014	205.30M	94.41%
Dec 31, 2013	105.60M	599.34%
Dec 31, 2012	15.10M	-52.66%
Dec 30, 2011	31.90M	66.15%
Dec 31, 2010	19.20M	68.42%
Dec 31, 2009	11.40M	-54.94%
Dec 31, 2008	25.30M	-41.44%
Dec 31, 2007	43.20M	-28.60%
Dec 29, 2006	60.50M	-20.81%
Nov 8, 2006	76.40M	-

View and export this data all the way back to 2006. Sign Up Today.

Related Stocks

Company	Market Cap
Ligand Pharmaceuticals	4.27B
Caris Life Sciences	4.11B
Veradermics	4.11B
NewAmsterdam Pharma Company	4.07B
Travere Therapeutics	3.96B
Crinetics Pharmaceuticals	3.88B
Oruka Therapeutics	3.74B
ACADIA Pharmaceuticals	3.66B